Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-06-18

Clinical Trial Update: Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of Beclomethasone Dipropionate and Formoterol Fumarate versus single components in asthmatic children has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beclomethasone Dipropionate (beclomethasone dipropionate)
  • FORMOTEROL FUMARATE (Formoterol fumarate dihydrate)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma in Children | Phase 3 | Status: WITHDRAWN